WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product - CSAR-BPAR CMAP, Biopsy Proven Acute Rejection (BPAR) can be assessed at defined time points, Serum Creatinine (SCr) is measured at post-transplant, Banff grade accounts for Mononuclear cell interstitial inflammation, Biopsy is performed for Cause, Banff grade is staged as IIA, Banff grade is staged as IA, Banff grade is staged as IIB, Clinically suspected Acute Rejection can be defined by urine output, Banff grade accounts for Vascular fibrous intimal thickening, Biopsy is performed for Surveillance (Protocol), post-transplant is measured at defined time points, Banff grade accounts for Interstitial fibrosis, Clinically suspected Acute Rejection includes Biopsy Proven Acute Rejection (BPAR), Banff grade is staged as III, Biopsy Proven Acute Rejection (BPAR) is confirmed by Biopsy, urine output is measured as decreased, Banff grade accounts for Arteriolar hyaline thickening, Biopsy Proven Acute Rejection (BPAR) is observed on a date, Banff grade accounts for Tubulitis, Biopsy is classified by Biopsy grade